Duchenne muscular dystrophy (DMD): investigations
Evidence-based neurology checklist on duchenne muscular dystrophy (dmd): investigations: Creatinine kinase (CK) This is increased 10 to 100-fold It falls with disease progression Muscle biopsy Magnetic resonance imaging (MRI): sites of atrophy and oedema Magnetic resonance imaging (MRI): spared…
Creatinine kinase (CK)
- This is increased 10 to 100-fold
- It falls with disease progression
Muscle biopsy
Magnetic resonance imaging (MRI): sites of atrophy and oedema
Magnetic resonance imaging (MRI): spared muscles
Genetic testing: techniques
Other investigations
References
- Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010; 9:77-93.
- Manzur AY, Kinali M, Muntoni F. Update on the management of Duchenne muscular dystrophy. Arch Dis Child 2008; 93:986-990.
- Manzur AY, Muntoni F. Diagnosis and new treatments in muscular dystrophies. JNNP 2009; 80:706-714.
- Araujo APQC, Saute JAM, Fortes CPDD, et al. Update of the Brazilian consensus recommendations on Duchenne muscular dystrophy. Arq Neuropsiquiatr 2023; 81:81-94.
Related checklists
- Duchenne muscular dystrophy (DMD): clinical features
- Duchenne muscular dystrophy (DMD): female carriers
- Duchenne muscular dystrophy (DMD): bone health management
- Duchenne muscular dystrophy (DMD): respiratory management
- Duchenne muscular dystrophy (DMD): cardiac management
- Duchenne muscular dystrophy (DMD): genetic treatments
- Duchenne muscular dystrophy (DMD): steroid management
- Duchenne muscular dystrophy (DMD): other treatments
- Duchenne muscular dystrophy (DMD): investigational treatments
